Clicky

Sanofi(SNYNF) News

Date Title
Jun 15 Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
Jun 15 Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Patients with Coexisting Asthma in First-ever Presented Phase 4 Head-to-Head Respiratory Trial
Jun 15 Berenberg Bank Remains a Buy on Sanofi (SNY), Sets a €118 Price Target
Jun 15 Regeneron, Sanofi Announce Positive Dupixent Results for Atopic Dermatitis
Jun 12 Novavax's COVID-Flu Combo Shot Shows Strong Immune Response
Jun 11 Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel
Jun 10 Sanofi (ENXTPA:SAN) Expands Beyfortus RSV Protection Production For Global Demand
Jun 10 Merck Secures FDA Nod for New RSV Antibody Enflonsia in Infants
Jun 9 Sanofi: Information concerning the total number of voting rights and shares - May 2025
Jun 9 Beyfortus Output Tripled As Sanofi, AstraZeneca Scale Up For RSV Season
Jun 9 Regeneron and Sanofi’s dupilumab shows promise in AD trial
Jun 9 Sanofi Appoints James Guy as Country Lead, Canada and General Manager, Specialty Care
Jun 9 Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season
Apr 25 Swiss Agree to Tariff Negotiations With Trump Administration
Apr 24 Pharma Giant Roche Tops First-Quarter Views; Sanofi's Sales Come In Mixed
Apr 24 Sanofi axes development of oral TNF inhibitor as monotherapy following Phase II fail
Apr 24 French Drugmaker Sanofi Clocks 20% Q1 Profit Growth, Forecasts Strong Rebound In Annual Profit
Apr 24 Sanofi Q1 Earnings Top Estimates, Dupixent Drives Sales Growth
Apr 24 Sanofi stays on course amid tariff turmoil
Apr 24 Sanofi Sales, Profit Beat Expectations on Higher Demand for Skin, Asthma Drug